Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Indolent lymphoma: the pathologist's viewpoint.

S A Pileri1, P L Zinzani, P Went

  • 1Pathologic Anatomy and Unit of Haematopathology, Institute of Haematology and Clinical Oncology 'L. & A. Seràgnoli', Bologna University, Bologna, Italy. pileri@almadns.unibo.it

Annals of Oncology : Official Journal of the European Society for Medical Oncology
|December 18, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cutaneous involvement in multiple myeloma. A rare entity.

Clinical case reports·2025
Same author

Clinicopathological definition, management and prognostic value of mogamulizumab-associated rash and other cutaneous events: A systematic review.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

BCL-2 expression in primary cutaneous follicle center lymphoma is associated with a higher risk of cutaneous relapses: A study of 126 cases.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

A case of pityriasis lichenoides et varioliformis acuta developed after first dose of Oxford-AstraZeneca COVID-19 vaccine.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Who is the culprit? A toxic epidermal necrolysis case in a patient treated with rituximab plus polatuzumab.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Estimating the incidence of COVID-19 skin manifestations on the general population in a territorial setting.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same journal

The ethical obligation to use positive trial results.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

Lorlatinib: The Crown Jewel of ALK Inhibitors.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

TROP2-Directed Antibody Drug Conjugates: New First-Line Treatment for All Patients with Advanced Triple-Negative Breast Cancer?

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

When artificial intelligence learns to abstain: towards clinically responsible diagnostic support in liver pathology.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

PRMT5 inhibitors in MTAP loss NSCLC with actionable genomic alterations: a new kid on the block?

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

Refining decision making in hormone receptor-positive early-stage breast cancer: moving from static to dynamic.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
See all related articles

Recent studies on indolent lymphomas, particularly marginal-zone lymphoma (MZL), reveal significant molecular differences between its subtypes. Further research is needed to refine classification and understand their origins.

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • Indolent lymphomas are under extensive research for improved understanding of their development and treatment.
  • Marginal-zone lymphoma (MZL) has seen significant advancements, making it a focus for current studies.

Purpose of the Study:

  • To review recent advancements and unresolved issues in marginal-zone lymphoma (MZL).
  • To highlight the molecular heterogeneity within and between the three WHO-classified MZL categories.
  • To emphasize the need for refined diagnostic tools for better classification of MZL.

Main Methods:

  • Review of recent scientific literature on indolent lymphomas and MZL.
  • Analysis of molecular differences among MZL subtypes.
  • Discussion of the potential role of the IRTA gene family in MZL classification.

Related Experiment Videos

Main Results:

  • Despite a common origin hypothesis, the three MZL categories exhibit distinct molecular profiles.
  • Significant heterogeneity exists within each MZL group.
  • The IRTA gene family shows differential expression in B-cells, suggesting a role in MZL.

Conclusions:

  • Current classification of MZL may not fully capture its molecular complexity.
  • More sophisticated tools are required for accurate revision and grouping of MZL neoplasms.
  • The IRTA gene family represents a promising avenue for a deeper understanding of MZL.